We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| European Home | EHR | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 22.00 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 22.00 | 22.00 |
| Top Posts |
|---|
Posted at 15/3/2007 18:18 by bird of dawning I guess you might be looking to start a new shorters thread?! EHR could be an acronym for `Early Hard Rains.......gonna fall' (with acknowledgements to Bob Dylan).In its former Kleeneze (KLZ) guise, this company; Euro Home Retailing was engaged in the art of `bottom line management'. So.......as long as they showed a basic net profit each year, the bank would still lend out to this 80 years old, household name, Kleeneze business, with its relatively low cost network marketing (mlm) distributor catalogue retailing base. Albeit that the KLZ/EHR balance sheet showed up a perennial net loss value and was permanently strapped for cash. Based on this premise......OK I'm pretty sure thats not a mispelling?! we could perhaps start off with the Robson Rhodes HGI Stockmarket unloved companies list: Actually, I would venture to comment that there's some pretty good ones shown here e.g. Costain. Perhaps the best sector to start in might be retailing? Therefore, perhaps we should take a new look at......New Look. I wouldn't expect to find to many shorters candidates here..... Vodafone!!?....well I guess that you can never really know whats exactly around the next corner. If R.R don't like Vofafone I can't imagine what they thought of EHR? perhaps it was already below the R.R event horizon and deep inside the black hole as early as 2004. Emblaze (BLZ) might be a candidate (its price has slipped over 30% today on UK VAT fears) though not on the R.R list however, its currently showing a net loss of $10m.....a gaff that would have meant `sudden death' for EHR. BLZ has the advantage over EHR in that its selling at 0.64 price/book and 1.63 Price/Sales, Emblaze balance sheet is really pretty healthy.....they could yet blaze their way through this mini-crisis quite well....a turnaround/recovery play?......therefore we must exclude it rom our shorters list. The magic shorting formula (EHR style) could be; consistent bottom line (minimal) profit c/w imbalance sheet. I'll be taking a New Look. Cheers bod |
Posted at 25/9/2006 01:31 by bird of dawning I seem to recall that back on ye olde `EHR with Charts & News' thread I made the last post; no.27 (+ also no.25) and maybe this post should have had an accompanying MP3 bugle soundtrack!....not that I'm in anyway gleeful at Kleeneze/EHR demise......but you had been warned about being "overstretched on the borrowing front".However!.......it looks to me that many previous posters on that thread then voted with their feet in order to stay within their KLZ/EHR (whats in a name?) comfort zone. That is not a very mlm thing to do!.....we're supposed to get out of our comfort zones.....just as the group distributor meeting pep talks are always reminding us. I'm a former Kleeneze distributor and still have a high regard for the company and its solid retailing base. Their fundamental flaw IMHO is that the very clear description of the Kleeneze networking opportunity on the back page of every catalogue complete with the Kleeneze commission structure, is misdirected. Why?!.....because its not duplicatable (mlm sacrilege!). Although the retail customers of Kleeneze are very loyal and love the catalogue, as well as using its products regularly with repeat orders.....THEY DON'T SEE THEMSELVES DOING IT!.....going out in December and January in the dark, cold and rain dropping catalogues door to door.....its all a matter of public perception.....right If Kleeneze placed an ad for discount (wholesale price deals) on the back cover of every catalogue, to lure the legions of regular retail customers, they would then become de facto distributors.....the famed `FUSION SALE'. My second observation (Gripe?) is that their entire catalogue should be on one website....a bit like Ebay or Quixtar (no!....I'm not an Amway distributor). Their catalogue would still be circulated as required, maintaining that so important `warm market' connection. I reckon that I'm staying on thread.....I've been floored once already....don't do it to me yet again guys.....its unchappish!.....get out of the comfort zone and into the Autumn sunshine with 400 catalogues per week.....but IMHO it needs a flyer to be included with it, offering a healthy discount for regular orders (say 20%); c/w direct debit and as a reward, a free sign up, as long as a monthly retail revenue of £20 product value is maintained. Regards bod www.moreinfo247.com/ |
Posted at 22/9/2006 20:22 by skintvestor earthian - as it happens, my partner and I are distributors. You are probably right in that at general distributor level, nobody realises what is going on.My guess is that EHR expanded too rapidly and overstretched themselves on the borrowing front. They invested in a brand new automated warehouse to compliment Kleeneze`s expansion into Holland and Germany. I only hope they are able to trade their way out of trouble. I`ve seen it with other companies. e.g. LCI |
Posted at 22/9/2006 18:24 by earthian At the risk of talking to myself on here ;) Just to let anyone with an interest in what might be going on know, I have sent an email to investor relations at EHR today. ...maybe if others do the same they might be shamed into updating us...? |
Posted at 22/9/2006 15:33 by earthian Hi skintinvestorI have spoken to a couple of Kleeneze distributors myself, since the suspension of share trading, to gauge how that part of the business is going. The responses I've had agree with your point - i.e. that trading is as normal - but also that at distributor level there is neither knowledge that the company may be in trouble, nor that the shares have been suspended! (This last point is probably not surprising - I doubt that the majority of distributors are even aware that it is a quoted company, never mind owning shares!) My concern here is to wonder to what extent the borrowing problem truly affects the future existence of EHR as a whole (some news from the company may help :) ), and how likely it is that they will recommence trading. This is the first time I've held shares in a company that has suspended share trading, but from knowledge of other companies it is, as she-ra said above, "not looking good at all." I wonder what the likely next steps are...? To split the company up so that Kleeneze trades as a separate entity from the newly acquired businesses like IWOOT? Or is this not possible having rebranded themselves as EHR? Some kind of reverse takeover? Anyone with any experience of similar situations, comments, etc., ...? |
Posted at 17/8/2006 21:09 by ygor SOLA is a future example of a 10 bagger, i.e. share price will rise to 10x its current level. EHR is an example of a 0.1 bagger, i.e. share price has fallen from 200p to a tenth of that. You want to buy the former and avoid the latter, as a good general rule. |
Posted at 02/8/2006 09:23 by skintvestor The following article is why I think EHR will eventually bounce back.LRI Industry Report Kleeneze and the Shakeout! Boom Will Kleeneze succeed in the new boom of Network Marketing in Europe? The 'Shakeout' stage of an industry's Lifecycle is when fortunes are made. It is the development stage that follows the wild and entrepreneurial 'Growth' stage when an industry is pioneered. It is the stage when Nokia, Microsoft, Vodafone, Dell, Body Shop and Google became famous. When the extra-ordinary growth and profits created extra-ordinary incomes. When owners and company leaders got rich. If an industry has major trends driving it then it's the Industry Lifecycle that provides the simple answer to the question - When should I join an industry? Joining an industry in the 'Birth' or 'Growth' stage has the greatest potential to grow YET there is a 99% chance that the business you joined will fail. The best time to join an industry is in the Shakeout stage [Point X]. The business concept is proven and markets pioneered. This is when the strong companies strengthen their businesses and sales explode. Network Marketing After its 'Growth Stage' boom pioneering 100 countries creating 80 billion in sales, Network Marketing/Direct Sales has now fundamentally changed and now entered it Shakeout Stage of Growth. In the past twenty years of its 'Growth' stage, every country has been opened, nearly every product and plan concept pioneered. The high 'Growth Stage' failure rate has meant that Network Marketing has attracted negative public image. After the recent boom in Network Marketing, some ask whether the growth opportunities are now finished. Those who had a negative experience or know other who did not succeed find it difficult to believe the industry could boom again. These people will miss out on a major financial opportunity. The WFDSA chart global sales of in US$ [on right] clearly shows the global boom, industry refocus period and now new boom - 30% global growth in just 3 years. What is does not show is that nearly every country is growing. A significant development is that the growth is lead by the big companies rather than new companies. The major reason for this is believed that the high failure rate of new companies in the Growth Stage means that Network Leaders, the key driver of growth, are only interested in secure successful companies. The new SHAKEOUT boom means that Network Marketing is the 'Right Place at the Right Time.' It is the perfect time to join the industry. Our only advice is that you must join a strong company. Kleeneze Kleeneze is becoming one of Europe's leaders in Network Marketing after becoming the No1 Network Marketing company in the UK. After years of continuous growth, it is begun its expansion across Europe and the reasons for its success are clear: 1. People buy from catalogues delivered to their home. Most people find something they want, especially with large ranges and low prices with convenient delivery. Thus the catalogues do the selling which overcomes one of the biggest blocks to making money in Network Marketing. 2. Kleeneze has perfected its catalogue and supply system, thus as long as catalogues go out, retail sales are made. This retail sales strength means networks can last for decades. 3. Kleeneze's leadership opportunity has proven itself against the world's best in the UK where it has grown to No1 status in sales with many leaders on residual incomes. Competitive commissions, car plan and travel incentives plus the security of public-listed status ensures appeal to new people wanting a leadership rewards. For the reasons above, LRI believes Kleeneze has a competitive and unique market offer. There does not see any restriction to growth across Europe. Even in its home market of the UK, Kleeneze has reached less than 20% of its potential size. LRI is confident to predict that Kleeneze will be one of the companies to lead the Shakeout boom in Europe. Sales of in excess of 1billion are likely within a decade, limited only by the company expansion programme and network leadership. Ludbrook Research International [LRI] is strategic research company focused on the Direct Sales and hyper-growth industries. Edward Ludbrook is recognised as a world authority on the industry of Network Marketing who has sold more than 2 million books and audios in 20 languages. His new industry book - 'Shakeout!' explains why Network Marketing is booming again. For his FREE online newsletter go to www.ludbrook.com LRI or Mr Ludbrook has no financial involvement with Kleeneze and the company or its representatives has not paid or endorsed this independent report. This report is copyright protected yet this report may be used as a whole without the express permission of LRI. www.ludbrook.com |
Posted at 29/7/2006 20:38 by 13579 news...ehr |
Posted at 15/5/2006 18:49 by paulypilot She-ra,You said ... You say everything has its price but you thought that when Invox had a mkt cap of more than £55million where it now stands at £7.2 million unloved and in trouble. Yes that's perfectly true. So what ? As an investor, I get some investments right, and others wrong. The same is true of ALL investors. Invox was clearly one I got wrong, it happens. "it's not difficult to see these shares being a 4 or 5 bagger if management get it right." I love the way you dangle a carrot to the naive.Im sure you said the same with Invox. Ridiculous !! Again you assign some sort of imaginary motive to me, which exists only in your head. Can you not understand that I'm just expressing my opinions on a share, that's all. I wish you would add a caveat that if it doesnt (and it may not be its fault if it cant-i.e world economic slump,even China's looking wobbly) sort the problems out then this company could go to the wall. Why should I have to add any sort of caveat ? People can read the accounts, and make their own minds up. You talk as if investors are mindless lemmings, unable to make up their own minds on the merits of a particular share. You should have a bit more faith in your fellow investors, people are a lot more savvy than you seem to believe. Of course EHR is vulnerable to an economic downturn, as all companies are. In terms of its direct selling model, it could be argued that EHR is actually much more recession-proof than a bricks & mortar retailer (whose cost base is largely fixed, mainly rent+rates, plus semi-fixed wages costs). I used to be a retail FD, so understand this point better than most. EHR on the other hand has no such fixed cost base, as it operates through door-to-door agents, paid on commission. Personally I'm not that convinced about the long-term future of door-to-door selling - it's an outdated concept - people much prefer to buy things all in one go at Tesco/Asda. Naturally, if trading at EHR went badly wrong (which it has NOT done as yet, as far as we know), and the company racked up large losses, then yes I agree that there is nothing in the way of downside protection from the Balance Sheet. So in that scenario, you are perfectly correct to state that EHR could be vulnerable to going under. On the other hand, it could dispose of parts of the group to repay debt. The obvious route would be to IPO Kitbag.com and IWOOT. Both websites seem to be performing very well. The trading update mentioned Kitbag not being able to cope with demand at Xmas (from memory), which is a pretty good problem to have. To my mind, investing in these shares is not about pretending that this is a great company with great prospects. It's actually about weighing up the bad news, factoring in the possibility of more bad news, and then looking at what the upside might be if trading improves (and there were some positive signals in the last set of accounts). For me, at £24m mkt cap, the upside potential outweighs the downside risk. Clearly you disagree, that's what makes a market !! (and a bulletin board) Paul. |
Posted at 15/5/2006 16:55 by paulypilot She-ra. I've held 7% of IndigoVision since 2004. I'll leave you to do the sums.And can you please stop personalising everything. This board is here to discuss EHR, not my personal finances ! But if you sling (misinformed) mud at me, I'll sling it straight back at you mate. As for EHR, there is nothing whatsoever to suggest that it might go bust. Sure the Balance Sheet is fairly weak, but that only presents a problem if a company is loss-making, which this isn't. The current market cap is probably less than Kitbag.com & Iwoot.com are worth alone, with the rest of the business thrown in for free. The interesting thing with EHR is that the factors which caused the deterioration in profitability (e.g. trading losses at the Ezee TV) have already been dealt with, but will drop out into future results. So looking ahead, there is a perfectly sensible rationale for expecting a turnaround in profits. It may or may not happen, we'll just have to wait & see. Equally, the downside is that management might screw things up again & issue another profits warning. That's the call that we have to make as investors. I just think the current mkt cap is sufficiently low to make the risk worth taking, as there's considerable upside if profitability recovers. But there's no guarantee that profitability will recover, of course. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
